Health Technology Assessment

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer

  • Type:
    Extended Research Article
  • Authors:
    Clegg A, Scott D, Sidhu M, Hewitson P, Waugh N.
  • Journal:
    Health Technology Assessment
  • Issue:
    Volume: 5, Issue: 32
  • Published:
  • Citation:
    Clegg A, Scott D, Sidhu M, Hewitson P, Waugh N. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Health Technol Assess 2002;5(32). https://doi.org/10.3310/hta5320
  • DOI:
    https://doi.org/10.3310/hta5320
Crossmark status check

Toolkit

View Award

The full text of this issue is available as a PDF document from the Toolkit section on this page

We are currently working on improvements to this feature. Please check back soon for updates